Cargando…
Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate
PURPOSE: Prostatic carcinoma is a common and growing public health problem. Histological evaluation is fairly adequate for assessing tumor differentiation, but tumor proliferative activity is difficult to measure. Increasing evidence suggests that the factors controlling cell cycle progression also...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society (APPS)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099400/ https://www.ncbi.nlm.nih.gov/pubmed/25032195 http://dx.doi.org/10.12954/PI.14041 |
_version_ | 1782326483206799360 |
---|---|
author | Gupta, Veena Garg, Monika Chaudhry, Manish Singh, Sunita Sen, Rajeev Gill, Meenu Sangwaiya, Ashok |
author_facet | Gupta, Veena Garg, Monika Chaudhry, Manish Singh, Sunita Sen, Rajeev Gill, Meenu Sangwaiya, Ashok |
author_sort | Gupta, Veena |
collection | PubMed |
description | PURPOSE: Prostatic carcinoma is a common and growing public health problem. Histological evaluation is fairly adequate for assessing tumor differentiation, but tumor proliferative activity is difficult to measure. Increasing evidence suggests that the factors controlling cell cycle progression also modulate the rate of ribosome biogenesis. Despite the influence of cyclin D1 and argyrophilic nuclear organizer region (AgNOR) on prostate cancer proliferation, few studies have evaluated the diagnostic importance of these markers. Therefore, the present study was carried out to analyze the diagnostic value of the proliferative markers cyclin D1 and AgNOR in various prostatic lesions and to determine whether any association or relation between these markers and different Gleason grades exists. METHODS: A total 50 cases of various prostatic lesions were studied. Tumor grade, AgNOR staining, and cyclin D1 expression were evaluated in all cases. Correlations between the intensity and differential localization of these markers and Gleason grades were evaluated. RESULTS: The mean AgNOR count in cases of prostatic intraepithelial neoplasia was high compared with cases of benign prostatic hyperplasia (BPH) but lower than that of carcinoma cases. The intensity of cyclin D1 expression was high in carcinoma. A total of 14 cases (46.67%) showed strong positivity. No significant correlation was found between the intensity of cyclin D1 expression, AgNOR count, and histologic grades of prostatic carcinoma, whereas a significant correlation was observed between intensity and percentage expression of cyclin D1 in BPH and carcinoma (P<0.01). Nuclear as well as cytoplasmic positivity was seen among various grades of carcinoma. CONCLUSIONS: AgNOR count and cyclin D1 may be helpful in distinguishing between BPH and carcinoma of the prostate but may not be used as reliable indicators of the grade of prostatic adenocarcinoma because of overlapping values in various grades. However, further studies on larger samples are required to elucidate the role of these markers in identification of premalignant lesions. |
format | Online Article Text |
id | pubmed-4099400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Asian Pacific Prostate Society (APPS) |
record_format | MEDLINE/PubMed |
spelling | pubmed-40994002014-07-16 Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate Gupta, Veena Garg, Monika Chaudhry, Manish Singh, Sunita Sen, Rajeev Gill, Meenu Sangwaiya, Ashok Prostate Int Original Article PURPOSE: Prostatic carcinoma is a common and growing public health problem. Histological evaluation is fairly adequate for assessing tumor differentiation, but tumor proliferative activity is difficult to measure. Increasing evidence suggests that the factors controlling cell cycle progression also modulate the rate of ribosome biogenesis. Despite the influence of cyclin D1 and argyrophilic nuclear organizer region (AgNOR) on prostate cancer proliferation, few studies have evaluated the diagnostic importance of these markers. Therefore, the present study was carried out to analyze the diagnostic value of the proliferative markers cyclin D1 and AgNOR in various prostatic lesions and to determine whether any association or relation between these markers and different Gleason grades exists. METHODS: A total 50 cases of various prostatic lesions were studied. Tumor grade, AgNOR staining, and cyclin D1 expression were evaluated in all cases. Correlations between the intensity and differential localization of these markers and Gleason grades were evaluated. RESULTS: The mean AgNOR count in cases of prostatic intraepithelial neoplasia was high compared with cases of benign prostatic hyperplasia (BPH) but lower than that of carcinoma cases. The intensity of cyclin D1 expression was high in carcinoma. A total of 14 cases (46.67%) showed strong positivity. No significant correlation was found between the intensity of cyclin D1 expression, AgNOR count, and histologic grades of prostatic carcinoma, whereas a significant correlation was observed between intensity and percentage expression of cyclin D1 in BPH and carcinoma (P<0.01). Nuclear as well as cytoplasmic positivity was seen among various grades of carcinoma. CONCLUSIONS: AgNOR count and cyclin D1 may be helpful in distinguishing between BPH and carcinoma of the prostate but may not be used as reliable indicators of the grade of prostatic adenocarcinoma because of overlapping values in various grades. However, further studies on larger samples are required to elucidate the role of these markers in identification of premalignant lesions. Asian Pacific Prostate Society (APPS) 2014 2014-06-30 /pmc/articles/PMC4099400/ /pubmed/25032195 http://dx.doi.org/10.12954/PI.14041 Text en Copyright © 2014 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Gupta, Veena Garg, Monika Chaudhry, Manish Singh, Sunita Sen, Rajeev Gill, Meenu Sangwaiya, Ashok Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate |
title | Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate |
title_full | Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate |
title_fullStr | Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate |
title_full_unstemmed | Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate |
title_short | Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate |
title_sort | role of cyclin d1 immunoreactivity and agnor staining in the evaluation of benign and malignant lesions of the prostate |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099400/ https://www.ncbi.nlm.nih.gov/pubmed/25032195 http://dx.doi.org/10.12954/PI.14041 |
work_keys_str_mv | AT guptaveena roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate AT gargmonika roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate AT chaudhrymanish roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate AT singhsunita roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate AT senrajeev roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate AT gillmeenu roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate AT sangwaiyaashok roleofcyclind1immunoreactivityandagnorstainingintheevaluationofbenignandmalignantlesionsoftheprostate |